| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $45.9M | +5.5% | +11.4% |
| SG&A Expense | $18.1M | +0.5% | +20.2% |
| Operating Income | -$56.4M | -6.8% | +11.8% |
| Pre-tax Income | -$53.9M | -6.7% | +12.8% |
| Income Tax | $0 | — | — |
| Net Income | -$53.9M | -6.7% | +12.8% |
| EPS (Basic) | -$0.32 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $196.2M | -5.9% | -36.9% |
| Accounts Receivable | $10.0M | +518.4% | — |
| Current Assets | $215.5M | -3.6% | -33.6% |
| Total Assets | $241.4M | -4.3% | -32.7% |
| Current Liabilities | $85.9M | -1.7% | -49.7% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$153.7M | — | — |
| Capital Expenditures | $719K | — | — |
| Investing Cash Flow | -$719K | — | — |
| Financing Cash Flow | $48.5M | — | — |
| Free Cash Flow | -$154.4M | — | — |
| +31.9% |
| EPS (Diluted) | -$0.32 | -3.2% | +31.9% |
| $109.0M |
| +3.6% |
| -47.9% |
| Stockholders' Equity | $124.5M | -10.6% | -12.1% |